NCT00483639

Brief Summary

RATIONALE: Patients who undergo treatment for head and neck cancer may become anxious and avoid contact with other people. Learning how cancer treatment may cause anxiety in patients with head and neck cancer may help improve the quality of life in these patients. PURPOSE: This clinical trial is studying anxiety and avoidance of others in patients previously treated for head and neck cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2003

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2003

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2006

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

June 6, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 7, 2007

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2008

Completed
Last Updated

March 15, 2013

Status Verified

March 1, 2013

Enrollment Period

2.3 years

First QC Date

June 6, 2007

Last Update Submit

March 13, 2013

Conditions

Keywords

anxiety disorderlong-term effects secondary to cancer therapy in adultshead and neck cancernon-small cell lung cancersmall cell lung cancer

Outcome Measures

Primary Outcomes (1)

  • Level of social anxiety and avoidance in HNC patients post-treatment

    Measured by the Liebowitz Social Anxiety Scale and the Social Phobia and Anxiety Inventory, containing 24 items with each item separately rated for fear as 0 (none), 1 (mild), 2 (moderate) to 3 (severe)and for avoidance behavior as 0 (never), 1 (occasionally), 2 (often), to 3 (usually). Scores are summed with lower values indicating lower levels of social anxiety and avoidance.

    at study entry, day 1

Secondary Outcomes (3)

  • Relationship between pre-cancer psychiatric diagnosis and post-treatment social anxiety and avoidance

    at study entry

  • Quality of Life

    at study entry, day 1

  • Comparison of social anxiety and avoidance in patients with head and neck cancer to patients with lung cancer

    at study entry, day 1

Interventions

medical chart review

survey administration

Also known as: survey administration

management of therapy complications

psychosocial assessment

Also known as: psychosocial assessment

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

People who have been treated for head and neck cancer.

PATIENT CHARACTERISTICS: * Diagnosis of 1 of the following: * Head and neck cancer * Lung cancer (control group) * Must have received treatment for head and neck cancer or lung cancer within the past 5 years PATIENT CHARACTERISTICS: * Able to speak and read English to answer surveys, interviews, and questionnaires PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (2)

MBCCOP - Meharry Medical College - Nashville

Nashville, Tennessee, 37208, United States

Location

Vanderbilt-Ingram Cancer Center

Nashville, Tennessee, 37232-6838, United States

Location

MeSH Terms

Conditions

Anxiety DisordersHead and Neck NeoplasmsLung NeoplasmsCarcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma

Interventions

Psychiatric Rehabilitation

Condition Hierarchy (Ancestors)

Mental DisordersNeoplasms by SiteNeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesCarcinoma, BronchogenicBronchial Neoplasms

Intervention Hierarchy (Ancestors)

RehabilitationTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Kirsten Haman, PhD

    Vanderbilt-Ingram Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor; Psychologist

Study Record Dates

First Submitted

June 6, 2007

First Posted

June 7, 2007

Study Start

November 1, 2003

Primary Completion

March 1, 2006

Study Completion

January 1, 2008

Last Updated

March 15, 2013

Record last verified: 2013-03

Locations